Muna Therapeutics
Anders brings 25 years of experience in biotech leadership and venture capital investment.
Prior to joining Muna, he co-founded and was CEO of Orphazyme, creating an ambitious and mature clinical stage pipeline in rare protein misfolding and lysosomal storage diseases.
This person is not in any offices
Muna Therapeutics
1 followers
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.